Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2014-05-19
Original SEC Filing: Click here

---

Webplus: TPI/20140519/8-K/2_EX-99.1/000.htm SEC Original: f8k051514ex99i_tianyin.htm
TPI Reports Third Quarter Fiscal Year 2014 Financial Results Tianyin Pharmaceutical Inc. (NYSE Amex: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for the third quarter fiscal year 2014. Third Quarter Fiscal 2014 Ended March 31, 2014 Financial Highlights: · Revenue was $8.6

---

---

Webplus: TPI/20140519/8-K/3_EX-99.2/000.htm SEC Original: f8k051514ex99ii_tianyin.htm
Tianyin Pharmaceutical Inc. Third Quarter Fiscal Year 2014 Financial Results Conference Call May 15, 2014 Operator I will now turn the conference over to Dr. James Tong, Chief Financial Officer. Please go ahead. James Jiayuan Tong – Chief Financial Officer: Third quarter of fiscal year 2014 ended March 31, 2014 financial highlights. · Revenue was $8.6 million versus $15.5 million

---

---

Webplus: TPI/20140519/8-K/1/000.htm SEC Original: f8k051514_tianyinpharma.htm
CURRENT REPORT FOR ISSUERS SUBJECT TO THE FORM 8-K CURRENT REPORT May 15, 2014 Date of Report (Date of Earliest Event Reported) Tianyin Pharmaceutical Co, Inc. Delaware 000-52236 20-4857782 (State or other jurisdiction of incorporation) (IRS Employer Identification No.) 23rd Floor, Unionsun Yangkuo Plaza, No. 2, Block 3 South Renmin Road Chengdu, P. R. China, 610041 +011-86-28- 8551-6696 o o

---

Company Information:

Ticker: TPI, Company: TIANYIN PHARMACEUTICAL CO., INC., Type: 8-K, Date: 2014-05-19CIK: 0001362718, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
23RD FLOOR, UNIONSUN YANGKUO PLAZA
CHENGDU, P.R. 610041